Early Screening and Identification for Panvascular Diseases

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05485870

Enrollment

1000

Registered

2022-08-03

Start date

2022-07-01

Completion date

2024-12-31

Last updated

2022-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panvascular Diseases

Brief summary

Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis.

Detailed description

Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis by a multi-omics study.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* 1\. Patients with panvascular diseases; 2. Patients or guardians who agreed to join the study; 3. Patients who can complete the relevant examinations involved in this study;

Exclusion criteria

* patients with coagulation dysfunction.

Design outcomes

Primary

Measure	Time frame	Description
Any new stroke events	Up to 48 months	Incidence of any new ischemic or hemorrhagic stroke

Countries

China

Contacts

Primary ContactPeicong Ge, MD

gepeicong@163.com15010545727

Outcome results